21起交易超123亿美元!诺和诺德达成52亿美元并购,布局MASH晚期疗法 | 一周交易

创鉴汇
Oct 16

据创鉴汇不完全统计,上周(10月6日至10月12日)全球生物医药领域共披露21起交易事件,潜在交易总额超123亿美元。上周2起大额并购事件共计贡献了超50%的交易额,聚焦代谢和自免领域:10月9日,诺和诺德宣布将以52亿美元收购Akero Therapeutics。此次收购的核心资产是Akero的代谢候选药物Efruxifermin(EFX),一种成纤维细胞生长因子21(FGF21)类似物,治疗...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10